Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other financing activities (2016 - 2018)

Arcadia Biosciences (RKDA) has disclosed Other financing activities for 4 consecutive years, with $3000.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Other financing activities changed N/A year-over-year to $3000.0, compared with a TTM value of $1.3 million through Dec 2018, changed N/A, and an annual FY2018 reading of $1.3 million, changed N/A over the prior year.
  • Other financing activities was $3000.0 for Q3 2018 at Arcadia Biosciences, down from $373000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $5.6 million in Q2 2015 and bottomed at -$6.5 million in Q3 2015.
  • Average Other financing activities over 4 years is $333500.0, with a median of $239500.0 recorded in 2015.
  • The sharpest move saw Other financing activities crashed 93.31% in 2015, then plummeted 99.98% in 2016.
  • Year by year, Other financing activities stood at $1.6 million in 2014, then plummeted by 93.31% to $106000.0 in 2015, then crashed by 99.06% to $1000.0 in 2016, then skyrocketed by 200.0% to $3000.0 in 2018.
  • Business Quant data shows Other financing activities for RKDA at $3000.0 in Q3 2018, $373000.0 in Q2 2018, and $932000.0 in Q1 2018.